Mоlimо vаs kоristitе оvај idеntifikаtоr zа citirаnjе ili оvај link dо оvе stаvkе:
https://open.uns.ac.rs/handle/123456789/10916
Nаziv: | Fullerenol - A new nanopharmaceutic? | Аutоri: | Đorđević, Aleksandar Bogdanović G. |
Dаtum izdаvаnjа: | 1-дец-2008 | Čаsоpis: | Archive of Oncology | Sažetak: | Chemical modification of fullerenes to hydrosoluble cluster molecules made fullerenes interesting for biological investigation. Among them, polycarbonated and polyhydroxylated fullerene C60 derivatives showed the most interesting biological activities. In this paper, we present the most important recent results of in vitro and in vivo biological studies with fullerenol C60(OH)24. Fullerenol C60(OH)24 was strong antioxidant it reacted with superoxide anion radical, hydroxy radical and nitrous oxide radical in chemical and biological systems. Fullerenol C60(OH)24 did not inhibit human breast cancer cell growth at concentrations from 0.8 to 3.45 μM, but strongly modulated cytotoxic effects of doxorubicin and cis-platinum after 24 and 48 hours of treatment Radioprotective effects of fullerenol C60(OH)24 were shown in different in vitro and in vivo models. Fullerenol C60(OH)24 (100 mglkg) protected rat heart from doxorubicin toxicity. Biodistribution studies of fulelrenol were also investigated. Accumulating data from the literature and from our studies suggest that fullerenol, as a nanoparticle might be a new promising pharmaceutical in the near future. © 2008, Oncology Institute of Vojvodina, Sremska Kamenica. | URI: | https://open.uns.ac.rs/handle/123456789/10916 | ISSN: | 03547310 | DOI: | 10.2298/AOO0604042D |
Nаlаzi sе u kоlеkciјаmа: | PMF Publikacije/Publications |
Prikаzаti cеlоkupаn zаpis stаvki
SCOPUSTM
Nаvоđеnjа
37
prоvеrеnо 10.05.2024.
Prеglеd/i stаnicа
22
Prоtеklа nеdеljа
4
4
Prоtеkli mеsеc
0
0
prоvеrеnо 10.05.2024.
Google ScholarTM
Prоvеritе
Аlt mеtrikа
Stаvkе nа DSpace-u su zаštićеnе аutоrskim prаvimа, sа svim prаvimа zаdržаnim, оsim аkо nije drugačije naznačeno.